Branded

Gilead Sciences' Veklury has been approved to treat hospitalized patients with COVID-19 who are 12 years old and older.

The DOJ's settlement agreement will pave the way for Purdue to submit a plan of reorganization to the bankruptcy court that will transfer all of Purdue’s assets to a public benefit company.

Regeneron’s Inmazeb is the first FDA-approved treatment for Ebola virus infection in adult and pediatric patients.

Harmony's Wakix is the first and only non-scheduled treatment approved for excessive daytime sleepiness or cataplexy in adult patients with narcolepsy.

Merck’s Keytruda is the first anti-PD-1 therapy approved for adult patients with relapsed or refractory cHL after front-line therapy.

Sunovion’s Kynmobi is the first and only sublingual therapy for the on-demand treatment of off episodes in patients with Parkinson’s disease.

Bristol-Myers Squibb’s Opdivo, in combination with Yervoy, was approved by the FDA as a treatment for adults with malignant pleural mesothelioma that can't be removed by surgery.

Eton’s Alkindi Sprinkle is the first and only granular hydrocortisone formulation for adrenocortical insufficiency for children approved by the Food and Drug Administration.